Author

Cristina Rodríguez‐Antona

Consejo Superior de Investigaciones CientíficasORCID 0000-0001-8750-7338Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Javier LanillosiD· 2 shared Alberto CascóniD· 1 shared Alicia ArenasiD· 1 shared Andres SalumetsiD· 1 shared Aspasia DestouniiD· 1 shared Benelote UuskülaiD· 1 shared Carlos ValdiviaiD· 1 shared Cristina Montero‐CondeiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Javier LanillosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJan 6, 2026

Non-invasive Prenatal MT-RNR1 Pharmacogenetic Testing for the Prevention of Aminoglycoside-Induced Profound Hearing Loss

Aspasia Destouni, Benelote Uusküla, Javier Lanillos…·Kaarel Krjutškov

The paper develops a prenatal pharmacogenetic test using non-invasive prenatal testing data to identify variants in MT-RNR1 that predict risk of aminoglycoside-induced hearing loss with high accuracy.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 24, 2025

Identification of a novel papillary renal cell carcinoma molecular subtype characterized by HIF-pathway over-activation

Javier de Nicolás‐Hernández, Alicia Arenas, Carlos Valdivia…·Cristina Rodríguez‐Antona

This paper identifies a novel molecular subtype of papillary renal cell carcinoma (pRCC) characterized by HIF-pathway overactivation, associated with poor prognosis and distinct biological features.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky